We sold some of our Biotech holdings today. I don’t currently see any problems in this is industry or this particular ETF at this time. We only sold to use the funds in another endeavor. Price paid $89.36, price sold $117.12. The First Trust NYSE Arca Biotechnology Index Fund (FBT : $FBT) is still a great fund and I still recommend it to other investors. I wrote about FBT back in January 2017 and updated the charts in the article in May 2017 right here: Discovering Value in Growth Stock Funds: Biotech ETFs
We sold some of our Biotech equities today. (FBT : $FBT) No problem with the First Trust NYSE Arca Biotechnology Index Fund (FBT); just taking some profits off the table. Price paid $91.89. Price sold $119.87.
Here’s an article I wrote about FBT back in January 2017: Discovering Value in Growth Stock Funds: Biotech ETFs
Are Biotech Funds Buys Once Again?
While a number of market industries were fearful of a Trump Presidency, nowhere was the concern more prevalent than in the biotech and drug segment. After all, Trump came out several times against the pricing practices in the drug market, vowing to do something to make this a more affordable area…. (Read full article at Zacks.)
Check out this article about First Trust NYSE Arca Biotechnology Index Fund (FBT : $FBT) at NASDAQ: FBT’s Underlying Holdings Could Mean 11% Gain Potential